Contineum Therapeutics (CTNM) Income from Continuing Operations (2023 - 2026)
Contineum Therapeutics (CTNM) reported Income from Continuing Operations of -$15.09 million for Q2 2026, compared with -$15.87 million a year earlier.
Powered by 
Analysis
Contineum Therapeutics (CTNM) Income from Continuing Operations (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Contineum Therapeutics' Income from Continuing Operations came in at -$57.57 million; for FY2025, it came in at -$59.81 million.
- By year, Income from Continuing Operations came in at -$42.26 million in FY2024 and $22.72 million in FY2023.
- Five-year quarterly Income from Continuing Operations spans a low of -$15.87 million in Q2 2025 and a high of $41.57 million in Q2 2023.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$14.4 million (Q1 2026), -$15.11 million (Q4 2025) and -$12.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Contineum Therapeutics | 502.82 Mn | 502.82 Mn | - | -15.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15.09 Mn |
| Mar 31, 2026 | -14.40 Mn |
| Dec 31, 2025 | -15.11 Mn |
| Sep 30, 2025 | -12.98 Mn |
| Jun 30, 2025 | -15.87 Mn |
| Mar 31, 2025 | -15.86 Mn |
| Dec 31, 2024 | -14.57 Mn |
| Sep 30, 2024 | -10.27 Mn |
| Jun 30, 2024 | -9.01 Mn |
| Mar 31, 2024 | -8.42 Mn |
| Dec 31, 2023 | -7.77 Mn |
| Sep 30, 2023 | -6.25 Mn |
| Jun 30, 2023 | 41.57 Mn |
| Mar 31, 2023 | -4.82 Mn |
API Access
Contineum Therapeutics Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=CTNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "CTNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=CTNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();